chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm pain a couple days after vaccine; Arm swelling a couple days after vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain a couple days after vaccine) and PERIPHERAL SWELLING (Arm swelling a couple days after vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain a couple days after vaccine) and PERIPHERAL SWELLING (Arm swelling a couple days after vaccine). The patient was treated with MENTHOL (BIOFREEZE PAIN RELIEVING) ongoing since an unknown date for Pain and Swelling, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain a couple days after vaccine) and PERIPHERAL SWELLING (Arm swelling a couple days after vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. The patient's friend reported that patient had some arm swelling and pain a couple days after receiving the Moderna COVID-19 vaccine.
about 2wks p/vax devel red indurated area (1.5cm) @ vax site-followed 36hrs later by a vesicular eruption on trunk face & extremities w/fever Tmax 102 x 24 hrs;total of 23 lesions developed;all lesions crusted over by 23OCT95
she had Covid; likely it was thought she had Covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date 23Mar2021 (Lot number: EN6198) as dose 1, single and administration date 20Apr2021 (Lot number: EW0164) at the age of 68 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 2021, outcome "unknown", described as "she had Covid"; SUSPECTED COVID-19 (medically significant) with onset 2021, outcome "unknown", described as "likely it was thought she had Covid". The patient reported that she got desperately ill with the first shot. Then when she got the second dose, she called the hospital and they said that more than likely it was thought she had COVID. Her doctor told her that she was thought she had it before COVID had a name. The patient confirmed it was thought she had it but she was not tested and never had a positive test for COVID. The events did not require emergency room or physician office visit.   No follow-up attempts are possible. No further information is expected.
Local redness on right upper arm shortly after vaccine administration. Redness persisted and spread. Upper arm became edematous, red & warm to touch. Patient experienced some difficulty in breathing.
MUSCLE ACHES  FATIGUE  HEADACE    LASTED 2 DAYS    RESTED TOOK TYLENOL  FINE  3 RD DAY
This spontaneous report as received from a registered nurse (via MARRS # 1411USA002261) refers to a 3 day old female patient who on 21-OCT-2014 was vaccinated with improperly stored M-M-R II lot # J008153 (dose and route of administration were not reported). The outcome of the events (incorrect product storage and inappropriate schedule of vaccine administration were unknown). This is one of several reports from the same reporter. Additional information has been requested.
Just loss total hearing in right ear; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunization, reaction(s): "Just loss total hearing in right ear"; Bnt162b2 (2nd dose), for COVID-19 immunization, reaction(s): "Just loss total hearing in right ear". The following information was reported: DEAFNESS UNILATERAL (medically significant), outcome "unknown", described as "Just loss total hearing in right ear". Clinical course: Patient stated just loss total hearing in right ear. Read where Pfizer vaccine might cause this. I had all Pfizer Covid vaccinations and boosters. What do you know about this possibility.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I experienced ?normal? sore arm for 2 days, but by the 3rd day was having more pain with certain movements. After my 2nd vaccination it only got worse. Have had this for 4 months.
Patient was to receive Varicalla vaccine on 7/21/22. After the vaccine was administered, the administering nurse realized that the administered vaccine had been expired. The Lot Number for this expired vaccine is unavailable in the patient's chart, but the NDC is : 006-4827-01.
Developed Guillain-Barre syndrome approximately 1 week after vaccination with nasal flu vaccine. She required admission to PICU and received IVIG but is recovering nicely, should make full recovery.  Never required intubation but had tachycardia requiring monitoring.
LEFT SHOULDER PAIN; This spontaneous report received from a patient concerned a 63 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered at left arm on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced left shoulder pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of left shoulder pain was not reported. This report was non-serious.
16DEC93 pt recvd vax 16DEC93 1620 & 1625 c/o dizziness, nausea, diaphoresis; denied resp difficulty, pruritus or rashes-BP 110/70, HR 80; 1635 vomiting-resp status unchanged & no rashes/hives; 1640 refused DPH; 1645 BP 122/80 HR 88;
A non-serious spontaneous report of patient received expired FLUMIST was received from a health professional concerning a 13-year-old male. Neither medical history nor concomitant medication was reported for this patient. The product expired on 02-Jan-2011. On 05-Jan-2011, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
4 inch long 2 wide red rash at injection site, sore arm,  headache, nausea, and achy.
Vaccinee rec'd a series of 3 Engerix-B injects (deltoid) according to 0, 1, 6 mo schedule. About 1 mo following the third dose, results of testing for Hepatitis B surface Antibody indicated she had a low titer;
NEUROPATHY IN BOTH FEET THAT WENT UP HER LEGS/FINGERS AND HANDS; FEELING FLUSHED IN THE FACE; BODY ACHES; DIFFICULT TO WALK; SORE THROAT; SEVERE BONE PAIN; WORSE PAIN IN LEGS AND HIPS; FEELING FEVERISH; HEADACHE; WEAKNESS; FEELING VERY TIRED; SEVERE PAIN IN BOTH MUSCLE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included chemotherapy performed on an unspecified date in NOV-2020, patient had no known allergies as pre-existing medical conditions, The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported,1 total, administered on 14-SEP-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 14-SEP-2021, about 4 hours post vaccination, patient felt flushed in the face and feverish, although patient did not have a fever. Patient complained of a headache that would come and go for 2 days. Patient stated she had neuropathy in both feet that went up her legs and lasted over 24 hours, as well as neuropathy in her fingers and hands that was still persisted. Patient stated she had body aches described as both muscle and bone pain, that was so severe that it was difficult to walk. The pain begun 20 hours after the injection and lasted over 24 hours, and was worse in the legs and hips. Patient reported that 3 hours after the injection, she felt very tired, which lasted approximately 48 hours, as well as weakness that was associated with the body pain. Patient also experienced a sore throat. Patient compared the feeling to her chemotherapy treatment in NOV-2020. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, severe bone pain, worse pain in legs and hips, and severe pain in both muscle on SEP-2021, and headache, and feeling very tired on 16-SEP-2021, had not recovered from neuropathy in both feet that went up her legs/fingers and hands, and the outcome of feeling flushed in the face, feeling feverish, weakness, sore throat and difficult to walk was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210935168-COVID-19 VACCINE AD26.COV2.S-neuropathy in both feet that went up her legs/fingers and hands. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
This spontaneous report as received from a healthcare worker refers to a number of unspecified patients (demographics unknown). Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with M-M-R II (dose and lot number were not reported). Concomitant therapy was not reported. From approximately October 2013 through December 2013, the patients may have received M-M-R II whose temperatures were not monitored in a refrigerator. The reporter did not know the temperatures the vaccines were exposed to during this period of time or if any excursions occurred. M-M-R II was not supported due to lack of temperature data. No adverse symptoms were reported. This case is linked to the same source (MARRS# 1401USA005011 and 1401USA005012). Additional information has been requested.
Itchy, redness, 2inch by 1 inch red lesion. Firm to touch, hot
Adverse effect of other vaccines and biological substances, initial encounter on 2022-12-14.
Menstrual cycle lasting 2 weeks onset 2 days after vaccine administration.  Also had worsening of chronic vulvodynia.  Previously had been able to have sexual intercourse once per month around the time of ovulation, however after vaccine  my vulvar pain has worsened to the point that I am unable to have intercourse or even wear pants.
gum infection; Tooth infection; A spontaneous report was received from a consumer concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tooth/gum infection.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 09 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection. After this he had tooth/gum infection.  Treatment included amoxicillin.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), tooth/gum infection was unknown..
patient reported eye irritation and burning. denies blurry vision. patient was observed for  115-20 minutes. then felt better and was driven home
Discharge Provider: Primary Care Provider: NP Admission Date: 5/30/2022 Discharge Date: Jun 2, 2022  PRESENTING PROBLEM: Altered mental status, unspecified altered mental status type [R41.82] AMS (altered mental status) [R41.82] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is 81 year old female with past medical history significant for chronic hypercalcemia/hyperparathyroidism, chronic anemia/thrombocytosis/leukocytosis, history of PE/Eliquis, hypertension and chronic obstructive pulmonary disease presents to the hospital on 05/30 due to altered mental status.  Was found to have fever at the time of admit.  Mental status was felt to be back to baseline even at the time of admission.  Patient was noted to have a borderline abnormal urinalysis and was not started on antibiotics.  She was incidentally tested positive for COVID-19.  Admitted for observation. Fever was felt to be related to heat exposure as patient was sitting in son at the facility and had refused to come in and it was a very hot day.  However fever could have been related to urinary tract infection or COVID.  She was afebrile for the course of hospital stay. Urinalysis was abnormal but without symptoms it was felt to be asymptomatic pyuria however with presenting complaints of altered mental status, fever and subsequent positive urine cultures showing E coli> 100,000CFU, patient was started on Rocephin with plan for 3 day course of antibiotics. COVID-19 infection was felt to be asymptomatic and incidental. Patient did have history of hypercalcemia, has followed up with endocrinology and subsequently with general surgery, was offered parathyroidectomy but she did not want to pursue surgery anymore. Patient was noted to have downtrending hemoglobin and was also noted to have severe iron deficiency.  She received test does IV iron dextran in preparation for the whole dose however she developed anaphylaxis on 06/01 but did not need CPR.  She was immediately given epinephrine, Benadryl and Solu-Medrol.  She quickly recovered.  Next day she was back to her baseline. She was discharged back to her facility on 06/02.
got really sick; could not stand; Initial information regarding an unsolicited valid non-serious social media case through global digital media case received from a consumer/non-no health care professional (HCP) (patient's son) on 25-Nov-2020 .  This case involves Adult male patient who got really sick (illness) and could not stand (Dysstasia), while he received vaccine INFLUENZA VACCINE.  The patient's medical treatment(s), past vaccination(s) and family history were not provided. Patient was a smoker. Concomitant medication was not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site as a prophylactic vaccination.  On an unspecified date, (latency unknown) after the administration of vaccine, the patient got really sick (illness). It was reported that good thing that came out of getting sick that the patient could not stand (Dysstasia) to smoke anymore so the patient quit smoking.  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, outcome of the events were unknown.  There will be no information regarding the batch number of the case.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. During 2014, the patient was inoculated by a physician with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended. On or about 01-MAY-2016, the patient was treated by a physician and diagnosed with herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
The second shot was fairly bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single, Pfizer Covid vaccine series), for Covid-19 Immunization, reaction(s): "I had the first shot with mild symptoms".  The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "The second shot was fairly bad".  Additonal Information: The patient wanted to share her experience with my Pfizer Covid vaccine series for research. She was normally healthy 52 year old woman. She had the first shot with mild symptoms. The second shot was fairly bad.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
on day 7 (Friday) after shot my left arm formed a lump under the skin.  It was red and hot to touch.  Call the doctor and they recommended Benadryl .  Saturday, Sunday and Monday the lump started to decrease but the attached redness around the lump began to grow each day.  Went in to the doctor on Monday and she was not sure what it was a reaction or maybe a injection site infection.  She wanted to be on the safe side in case it was an injection side infection and put me on Keflex.    This is now 5 days later 1-30-21 and the lump is gone and slowly the redness is disappearing.  (Still have a little redness now)
Pt was driving home from vaccination and she had a sharp left sided chest pain.  She pulled over and resolved but has had intermittent left sides chest pain/pressure since.   On Monday 2/8 she was directed to go to the ED for evaluation.
Within 24 hours of imms - fever and fussiness 4 days post imms - shaking of head, arms and legsstarted seen in our office that day - admitted hospital. Hosp diagnosis - acute cerebellar ataxia following imms.  8/10/07 Received vax records from pcp which confirm RO lot & dose as reported.  8/14/07 Received hospital medical records which reveal patient experienced head titibations, irritability, crying inconsolably, shaky movements, fever & URI s/s 4 days s/p vax. Admitted 7/23-7/25/07.  Neuro consult done.  Developed rash in hospital.  Treated w/IV antibiotics FINAL DX: acute cerebellar ataxia, vaccine & viral URI induced, resolving; mildly abnormal renal US; and viral rash.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. Patient's medical history and concurrent condition was not reported. On 24-FEB-2015 the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) 0.5 ml, subcutaneously (lot # K008579, expiry date: 13-DEC-2015). No adverse effects reported. No product quality complaint (PQC) involved. This is one of several reports received  from the same source. Additional information has been requested.
Following vaccines, the pt had 4 episodes of turning purple, arm outstretched, eyes wide. Mom would pat him on the back and he would then take a breath ant turn very pale. Took the pt to the ER.
I received the vaccine on 09/27/2022 and later that evening I had a high fever, joint pain, skin hurt, and it was difficult to move for twelve hours. The joint pain lasted longer, and I had weakness. I contacted my doctor on 10/03/2022 and I was not given a prescription. The symptoms went away but returned at the end of October. I did not see my doctor put I took over the counter pain medication.
got sick, like flu.; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had a severe case of shingles) and covid-19. Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (1st dose received on an unknown date, refer case US2021AMR176026). Concurrent medical conditions included autoimmune disorder.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not reported. The patient received 2nd shot and got sick, like flu. The patient stated he/she was not critically ill, but pretty miserable for a while, afterwards it was wonderful to actually get out of the house. The patient had autoimmune conditions and fully believe that contributed to his/her rare side effects. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR176026:Same reporter
After receiving PPSV vaccine client stated that his "cheeks felt tight and his throat felt scratchy". Eyes became watery. Client also had redness on his face, chest, back, and arms. Client was assessed by nursing staff and was seen by our on-site physician. Client was also given generic BENADRYL and was observed for 30 min after vaccination. Client's redness did begin to subside following administration of BENADRYL and client reported that his throat and checks "felt normal" prior to leaving the clinic.
Headache, Myalgia, Arthralgia, Fever, Localized itching, redness, pain, swelling; chills, fatigue Narrative:
Immediately following administration of GARDASIL she was sitting on exam table, felt lightheaded and fainted. falling to floor.  Mother in room reported patients eyes rolled back - immediately was awake & alert to place - Right hip sore from fall.  Had normal vital signs.  Rested , drank fluids & went home within 30 minutes
Within 24 hours of receiving vaccines, child developed high fever (up to 103 degrees F), hands turned blue & child had short periods of altered behavior. Dx - febrile seizure.